Medelio, Crismarie R.

HRN: 13-41-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/11/2026
08/18/2026
ORAL
5ml
Q12
Abrassions
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines